PRECISE begins enrollment, looks to improve CT intervention
The trial will build off findings from PROMISE and PLATFORM, which looked at similar patient populations and involved many of the same investigators and operational staff.
American Heart Association, Duke Margolis Center issue call to action on cardiovascular disease prevention and treatment
A new collaboration between the two institutions aims to address continued challenges in access and affordability of cardiovascular care.
Scholarship to honor Kevin Thomas’ advocacy for underrepresented populations
The Kevin L. Thomas, MD Scholarship will be awarded to high school students interested in medical careers.
The DCRI welcomes new faculty member
Jessilyn Dunn, PhD, is a faculty member in Duke’s Departments of Biomedical Engineering; Biostatistics and Bioinformatics.
The past, present, and future of IPF research at the DCRI
The DCRI has been on the forefront of research into the chronic and fatal lung disease.
Little is known about the cause of idiopathic pulmonary fibrosis (IPF), a devastating disease that
TRANSFORM-HF team pioneers new type of clinical trial
One of the first DCRI studies of its kind could become a model for the future.
2019 Annual Report: Reducing Risk, Changing Paradigms
An ongoing DCRI clinical trial seeks to determine whether an experimental lipid treatment is effective in preventing a second cardiovascular event in patients who have already had a heart attack.
The DCRI’s Sheng Luo on the benefit of biostatistics
DCRI-led think tank addresses opportunities and challenges of digital technology in health care
The DCRI brought together national leaders to address the promise and challenges facing digital health technologies in the transformation of health care.
DCRI, University of Oxford to collaborate on chronic kidney disease study
EMPA-KIDNEY will study the effects of empagliflozin in CKD patients with and without diabetes.